FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma By Ogkologos - April 1, 2026 2 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study CA209-8UT (SWOG 1826) Source RELATED ARTICLESMORE FROM AUTHOR 2026 ESMO Breast Cancer Award Recipient Announced Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk of Posttransplant Cancer of the Same Cancer Type Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows in China MOST POPULAR Efficacy and Safety of Entrectinib in Advanced ROS1 Fusion–Positive Non–Small Cell... March 15, 2021 ESMO Congress 2021, 16-21 September September 2, 2021 New Drug Regimen Cures More Children with Aggressive B-Cell Lymphoma July 1, 2020 COVID-19 Pandemic Halts Cancer Care and Damages Oncologists’ Wellbeing [ESMO Press... September 13, 2020 Load more HOT NEWS Pink Speed Bump Reminds Drivers to Schedule Their Yearly Mammograms Garbage Men Finally Meet Cancer-Free Toddler After Bonding From Afar New on NCI’s Websites for September 2022 How Genomic Testing Brought Me a Sense of Control During Metastatic...
